T2 biomarkers and remission state in severe asthma treated by biologics. - Amsterdam 2025

Severe asthma: from the underlying mechanism to clinical remission

Chair(s): Fabio L. M. Ricciardolo, Stefania Principe

Session type: Oral presentation

T2 biomarkers and remission state in severe asthma treated by biologics.

Mare Sabbe

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Cytokine micro-environment in moderate-to-severe asthma with airway autoantibodies

Manali Mukherjee

Replay

Abstract

Slides

Mucus plugs correlate with small airway remodelling in Asthma: A multi-resolution study

Aileen Hsieh

Replay

Poster

Abstract

Slides

Evidence of efficacy of biologics in smokers with severe asthma in the SHARP CRC registry

Jérémy Charriot

Replay

Poster

Abstract

Slides

The depth at which nitric oxide is produced by the conducting airways in patients with asthma

Haopeng Xu

Replay

Poster

Abstract

Slides

Does the reversal of airway remodeling accompany asthma remission?

Grace Parraga

Replay

Abstract

Slides

On the disposition of airway mucus-plugs in asthma before and after treatment

Eveline Durom

Replay

Poster

Abstract

Slides

Tracking blood eosinophils over time: long-term trends in asthmatic patients from the COBRA cohort

Marina Guecamburu

Replay

Poster

Abstract

Slides

Circulating microRNAs as potential tools for asthma diagnosis and asthma severity risk prediction.

Elena V. Vorobeva

Replay

Poster

Abstract

Slides

Psoriatic arthritis and bronchial asthma: a poorly investigated connection

Rubina Giulia Girolamo

Replay

Poster

Abstract

Slides

T2 biomarkers and remission state in severe asthma treated by biologics.

Mare Sabbe

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}